Published March 4, 2026
| Version v1
Publication
Open
"In the face of the shortage and possible discontinuation of crystalline insulin vials, what is the most favorable alternative for preparing dextrose–insulin solutions for the management of hyperkalemic patients? In which regimen are they recommended?"
Authors/Creators
-
Centro de Información de Medicamentos de la Universidad Nacional
(Research group)1
-
Ilvar, Muñoz - Ramirez
(Supervisor)1
-
Vaca González, Claudia Patricia
(Project manager)2
-
Ballesteros Herrera, David
(Editor)1
-
Barrero Salinas, Santiago Andrés
(Project member)1
- Rosas Alfonso, Daniel José (Project member)1
-
1.
Universidad Nacional de Colombia
- 2. Universidad Nacional de Colombi
Description
According to the available scientific evidence, the best alternative to the use of crystalline insulin in the treatment of hypercalcemia is the ultra–short-acting insulin lispro; since it provides the greatest amount of information regarding its efficacy (which shows no significant differences compared to crystalline insulin), its safety profile has been studied, and it is considered safer for patients with renal impairment.
Files
Frente al desabastecimiento y posible discontinuación de los viales de insulina cristalina, ¿Cuál es la alternativa más favorable para la preparación de soluciones de dextrosa-insulina para el manejo de paciente h.pdf
Files
(436.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:166fb075b499ecaf2e8f360555ae4e06
|
436.1 kB | Preview Download |